LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 18

Search options

  1. Article ; Online: Jiawei Taohe Chengqi Decoction attenuates hepatic fibrosis by preventing activation of HSCs through regulating Src/ERK/Smad3 signal pathway.

    Huang, Yan / Wang, Zhi-Li / He, Yi / Ye, Lin-Mao / Guo, Wen-Qin / Zhang, Jun-Jie

    Journal of ethnopharmacology

    2022  Volume 305, Page(s) 116059

    Abstract: Ethnopharmacological relevance: Jiawei Taohe Chengqi Decoction (JTCD) is a Traditional Chinese Medicine (TCM) formula modified from Taohe Chengqi Decoction in the classic ancient literature of TCM "Treatise on Febrile Diseases". Clinical and ... ...

    Abstract Ethnopharmacological relevance: Jiawei Taohe Chengqi Decoction (JTCD) is a Traditional Chinese Medicine (TCM) formula modified from Taohe Chengqi Decoction in the classic ancient literature of TCM "Treatise on Febrile Diseases". Clinical and pharmacological studies have shown that JTCD has a therapeutic effect on hepatic encephalopathy, non-alcoholic fatty liver, cirrhotic ascites, and can alleviate acute liver injury in rats. Our previous studies confirmed that JTCD could alleviate hepatic fibrosis and activation of hepatic stellate cells (HSCs). However, its mechanism remains unclear.
    Aim of the study: This study aimed to elucidate the mechanism of Src Signal on hepatic fibrosis and HSCs activation, and whether JTCD inhibited hepatic fibrosis and HSCs activation through affecting Src Signal.
    Materials and methods: In vivo, sixty specific pathogen free male C57/BL6 mice were divided into following six groups: Control group, Model group, SARA group, JTCD low dose group, JTCD medium dose group and JTCD high dose group. Then we established a carbon tetrachloride (CCL
    Results: We identified 135 chemical components in the water extract of JTCD, and the water extract of JTCD contains a variety of anti-hepatic fibrosis components. Compared to the model group, hepatic fibrosis performance was significantly improved, the serum levels of ALT and AST were significantly decreased in JTCD groups and SARA group, IHC staining and western blot results indicated that JTCD decreased the expressions of α-smooth muscle actin (α-SMA), phospho-Src (Tyr416), phospho-ERK1/2 and phospho-Smad3. In vitro, JTCD-containing serum could significantly decrease the protein expressions of α-SMA, phospho-Src (Tyr416), phospho-ERK1/2 and phospho-Smad3 according to the results of western-blot and immunofluorescence, in addition, JTCD-containing serum inhibited the mobility and activation of LX-2. What's more, after intervening with Src-shRNA, ERK1/2 agonists/inhibitors and JTCD-containing serum, the western-blot results showed that Src/ERK/Smad3 signal has an important role in hepatic fibrosis and HSCs, and JTCD attenuates hepatic fibrosis by preventing activation of HSCs through regulating Src/ERK/Smad3 signal pathway.
    Conclusions: The results showed that Src kinase promoted hepatic fibrosis and HSCs activation through the ERK/Smad3 signal pathway. More importantly, the mechanism by which JTCD attenuated hepatic fibrosis and HSCs activation was by inhibiting the Src/ERK/Smad3 signal pathway.
    MeSH term(s) Animals ; Humans ; Male ; Mice ; Carbon Tetrachloride/pharmacology ; Hepatic Stellate Cells ; Liver ; Liver Cirrhosis/chemically induced ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/metabolism ; MAP Kinase Signaling System ; RNA, Small Interfering ; Signal Transduction ; Smad3 Protein/metabolism ; Transforming Growth Factor beta1/metabolism
    Chemical Substances Carbon Tetrachloride (CL2T97X0V0) ; RNA, Small Interfering ; Smad3 Protein ; SMAD3 protein, human ; Transforming Growth Factor beta1
    Language English
    Publishing date 2022-12-19
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2022.116059
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Gastrointestinal Safety Profiles Differ Among Non-Vitamin K Antagonist Anticoagulants?

    Guo, Wen-Qin / Li, Lang

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

    2017  Volume 15, Issue 11, Page(s) 1811–1812

    MeSH term(s) Anticoagulants ; Atrial Fibrillation ; Gastrointestinal Hemorrhage ; Humans ; Thromboembolism
    Chemical Substances Anticoagulants
    Language English
    Publishing date 2017-06-07
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2119789-1
    ISSN 1542-7714 ; 1542-3565
    ISSN (online) 1542-7714
    ISSN 1542-3565
    DOI 10.1016/j.cgh.2017.05.038
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Complete Versus Culprit-Only Intervention in Patients With ACS: Does the Duration of DAPT Matter?

    Guo, Wen-Qin / Zhao, Hong-Lei / Chen, Xie-Hui

    Journal of the American College of Cardiology

    2019  Volume 73, Issue 4, Page(s) 532–533

    MeSH term(s) Acute Coronary Syndrome ; Drug-Eluting Stents ; Humans ; Percutaneous Coronary Intervention ; Platelet Aggregation Inhibitors
    Chemical Substances Platelet Aggregation Inhibitors
    Language English
    Publishing date 2019-03-18
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 605507-2
    ISSN 1558-3597 ; 0735-1097
    ISSN (online) 1558-3597
    ISSN 0735-1097
    DOI 10.1016/j.jacc.2018.11.029
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Angiotensin converting enzyme inhibitors for heart failure with reduced ejection fraction or left ventricular dysfunction: A complementary network meta-analyses.

    Guo, Wen-Qin / Li, Lang

    International journal of cardiology

    2016  Volume 214, Page(s) 10–12

    MeSH term(s) Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Bayes Theorem ; Heart Failure/drug therapy ; Heart Failure/physiopathology ; Humans ; Network Meta-Analysis ; Ramipril/therapeutic use ; Stroke Volume ; Survival Analysis ; Treatment Outcome ; Ventricular Dysfunction, Left/drug therapy ; Ventricular Dysfunction, Left/physiopathology
    Chemical Substances Angiotensin-Converting Enzyme Inhibitors ; Ramipril (L35JN3I7SJ)
    Language English
    Publishing date 2016-07-01
    Publishing country Netherlands
    Document type Journal Article ; Meta-Analysis
    ZDB-ID 779519-1
    ISSN 1874-1754 ; 0167-5273
    ISSN (online) 1874-1754
    ISSN 0167-5273
    DOI 10.1016/j.ijcard.2016.03.173
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The Net Clinical Benefit of Rivaroxaban for Patients With Acute Coronary Syndrome.

    Ye, Zi-Liang / Guo, Wen-Qin / Li, Lang

    Journal of the American College of Cardiology

    2018  Volume 72, Issue 19, Page(s) 2411–2412

    MeSH term(s) Acute Coronary Syndrome ; Factor Xa Inhibitors ; Hemorrhage ; Humans ; Rivaroxaban
    Chemical Substances Factor Xa Inhibitors ; Rivaroxaban (9NDF7JZ4M3)
    Language English
    Publishing date 2018-11-08
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 605507-2
    ISSN 1558-3597 ; 0735-1097
    ISSN (online) 1558-3597
    ISSN 0735-1097
    DOI 10.1016/j.jacc.2018.07.101
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Sex-Based Differences in the Association Between Nonalcoholic Fatty Liver Disease and Mortality.

    Ye, Zi-Liang / Guo, Wen-Qin / Li, Lang

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

    2018  Volume 17, Issue 1, Page(s) 211–212

    MeSH term(s) Cardiovascular Diseases ; Female ; Humans ; Neoplasms ; Non-alcoholic Fatty Liver Disease ; Risk Factors
    Language English
    Publishing date 2018-08-09
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2119789-1
    ISSN 1542-7714 ; 1542-3565
    ISSN (online) 1542-7714
    ISSN 1542-3565
    DOI 10.1016/j.cgh.2018.08.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Non-VKA Oral Anticoagulant and Risk of Myocardial Infarction: Paradoxical Procoagulant Effect of Warfarin?

    Ye, Zi-Liang / Guo, Wen-Qin / Li, Lang

    Journal of the American College of Cardiology

    2018  Volume 72, Issue 17, Page(s) 2093

    MeSH term(s) Anticoagulants ; Atrial Fibrillation ; Humans ; Myocardial Infarction ; Warfarin
    Chemical Substances Anticoagulants ; Warfarin (5Q7ZVV76EI)
    Language English
    Publishing date 2018-10-18
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 605507-2
    ISSN 1558-3597 ; 0735-1097
    ISSN (online) 1558-3597
    ISSN 0735-1097
    DOI 10.1016/j.jacc.2018.07.091
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Differences In Gastrointestinal Safety Profiles Among Novel Oral Anticoagulants: Evidence From A Network Meta-Analysis.

    Guo, Wen-Qin / Chen, Xie-Hui / Tian, Xiao-Yuan / Li, Lang

    Clinical epidemiology

    2019  Volume 11, Page(s) 911–921

    Abstract: Background: There is no consensus at present regarding the differences in the risk of GI bleeding across various NOAC regimens. Therefore, we performed a network meta-analysis to compare the risk of gastrointestinal bleeding after different NOAC ... ...

    Abstract Background: There is no consensus at present regarding the differences in the risk of GI bleeding across various NOAC regimens. Therefore, we performed a network meta-analysis to compare the risk of gastrointestinal bleeding after different NOAC regimens.
    Methods: PubMed, Cochrane, Web of Science, Clinicaltrial.gov and Clinicaltrialresults.org were searched for randomized controlled trials (RCTs) assessing gastrointestinal bleeding of all NOAC regimens from inception to January 2018. The primary endpoint was major gastrointestinal (MGI) bleeding. The meta-regression was performed to access the association between the MGI bleeding events and mortality. The network meta-analysis was carried out with the Bayesian random-effect model.
    Results: A total of 25 RCTs, including 139,392 patients, were identified. Meta-regression analysis showed that MGI bleeding was correlated with fatal bleeding events (odds ratios [OR], 1.76; 95% confidence interval [CI], 1.13-2.77], P=0.015). The network meta-analysis results showed that compared to the conventional regimens, rivaroxaban was associated with increased risk of MGI bleeding (OR, 1.37; 95% credible interval [CrI], 1.00-1.85), but not the apixaban (OR, 0.77; 95% CrI, 0.53-1.07]), edoxaban (OR, 0.86; 95%CrI, 0.52-1.18) and dabigatran etexilate (OR, 1.22; 95% CrI, 0.82-1.69). Compared to rivaroxaban, apixaban (OR, 0.56; 95% CrI, 0.35-0.88) and edoxaban (OR, 0.62; 95% CrI, 0.35-0.96) showed a significantly lower risk of MGI bleeding. Apixaban had the highest probability of being the safest option with regard to the risk of MGI bleeding (89.1%), followed by edoxaban (77.4%), conventional therapy (51.4%), dabigatran etexilate (23.8%) and rivaroxaban (8.3%).
    Conclusion: The risk of GI bleeding significantly varies among different NOAC regimens, and evidence shows that apixaban and edoxaban had the most favorable MGI bleeding safety profile, while rivaroxaban and dabigatran etexilate were the least safe.
    Language English
    Publishing date 2019-10-01
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 2494772-6
    ISSN 1179-1349
    ISSN 1179-1349
    DOI 10.2147/CLEP.S219335
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Safety of Alpha-Adrenergic Receptor Antagonists in Heart Failure.

    Guo, Wen-Qin / Zhao, Ling-Yue / Zhao, Hong-Lei / Chen, Xie-Hui

    JACC. Heart failure

    2019  Volume 7, Issue 3, Page(s) 276

    MeSH term(s) Adrenergic alpha-Antagonists ; Adrenergic beta-Antagonists ; Heart Failure ; Humans
    Chemical Substances Adrenergic alpha-Antagonists ; Adrenergic beta-Antagonists
    Language English
    Publishing date 2019-02-28
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2705621-1
    ISSN 2213-1787 ; 2213-1779
    ISSN (online) 2213-1787
    ISSN 2213-1779
    DOI 10.1016/j.jchf.2018.11.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The Optimal Duration of Dual-Antiplatelet Therapy After Coronary Stenting: Shorter or Longer?

    Guo, Wen-Qin / Li, Lang / Su, Qiang

    Journal of the American College of Cardiology

    2017  Volume 70, Issue 17, Page(s) 2208–2210

    MeSH term(s) Hemorrhage ; Humans ; Platelet Aggregation Inhibitors ; Stents
    Chemical Substances Platelet Aggregation Inhibitors
    Language English
    Publishing date 2017-10-19
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 605507-2
    ISSN 1558-3597 ; 0735-1097
    ISSN (online) 1558-3597
    ISSN 0735-1097
    DOI 10.1016/j.jacc.2017.07.796
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top